Received: from FRRPR02MB12349.eurprd02.prod.outlook.com (2603:10a6:d10:1cd::10) by PA4PR02MB7085.eurprd02.prod.outlook.com with HTTPS; Mon, 15 Jun 2026 11:50:51 +0000 Received: from GV2PR02MB11921.eurprd02.prod.outlook.com (2603:10a6:150:351::5) by FRRPR02MB12349.eurprd02.prod.outlook.com (2603:10a6:d10:1cd::10) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.113.18; Mon, 15 Jun 2026 11:50:50 +0000 Received: from GV2PR02MB11921.eurprd02.prod.outlook.com ([fe80::9f24:8c81:10e8:7104]) by GV2PR02MB11921.eurprd02.prod.outlook.com ([fe80::9f24:8c81:10e8:7104%4]) with mapi id 15.21.0113.013; Mon, 15 Jun 2026 11:50:50 +0000 From: "Kristi Sarap - RA" To: "Hanneli Rudi" References: In-Reply-To: Subject: Palve EBUst Date: Mon, 15 Jun 2026 14:50:49 +0300 Message-ID: MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_00F3_01DD07B8.946CD440" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQHZqoIQxGgZNN4n7jGbd9YJGhM6HQI1XvG/ Authentication-Results: dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=ravimiamet.ee; X-MS-Has-Attach: X-MS-Exchange-Organization-SCL: 1 X-MS-TNEF-Correlator: x-codetwoprocessed: true x-codetwo-clientsignature-inserted: true X-MS-Exchange-Organization-MessageDirectionality: Originating X-MS-Exchange-Organization-AuthSource: GV2PR02MB11921.eurprd02.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Internal X-MS-Exchange-Organization-AuthMechanism: 04 X-MS-Exchange-Organization-Network-Message-Id: cf22e3af-f1d4-4617-773a-08decad4588c X-MS-PublicTrafficType: Email X-MS-TrafficTypeDiagnostic: GV2PR02MB11921:EE_|FRRPR02MB12349:EE_|PA4PR02MB7085:EE_ X-MS-Exchange-Organization-ExpirationStartTime: 15 Jun 2026 11:50:50.9449 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Office365-Filtering-Correlation-Id: cf22e3af-f1d4-4617-773a-08decad4588c X-MS-Exchange-AtpMessageProperties: SA X-Microsoft-Antispam: BCL:0;ARA:13230040|23010399003|31052699007|39142699007|366016|56012099006|55112099003|11063799006|8096899003|18002099003|22082099003|13003099007|41050700001; X-Forefront-Antispam-Report: CIP:255.255.255.255;CTRY:;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:GV2PR02MB11921.eurprd02.prod.outlook.com;PTR:;CAT:NONE;SFS:(13230040)(23010399003)(31052699007)(39142699007)(366016)(56012099006)(55112099003)(11063799006)(8096899003)(18002099003)(22082099003)(13003099007)(41050700001);DIR:INT; X-MS-Exchange-Organization-Recipient-P2-Type: Bcc X-MS-Exchange-CrossTenant-OriginalArrivalTime: 15 Jun 2026 11:50:49.9440 (UTC) X-MS-Exchange-CrossTenant-FromEntityHeader: Hosted X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-AuthSource: GV2PR02MB11921.eurprd02.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Internal X-MS-Exchange-CrossTenant-Network-Message-Id: cf22e3af-f1d4-4617-773a-08decad4588c X-MS-Exchange-CrossTenant-MailboxType: HOSTED X-MS-Exchange-CrossTenant-UserPrincipalName: 7ACgqo25GeyDcqjrcRp03atnJDIJAECUn6rBiAYMHWseIDUw3RdXf5RrLG4O7vjYGXR4GXcEgZsKx5Y7vA1m8lRWquvuXHdHOb0cZ8AMRSehS95hXZfaGooZL59jPWFg X-MS-Exchange-Transport-CrossTenantHeadersStamped: FRRPR02MB12349 X-MS-Exchange-Transport-EndToEndLatency: 00:00:01.7308992 X-MS-Exchange-Processed-By-BccFoldering: 15.21.0113.000 X-MS-Exchange-ExternalInOutlookResult: NotEnabled X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(425001)(930201)(20251009189)(140003); X-Microsoft-Antispam-Message-Info: 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 Content-Language: et x-ms-exchange-organization-originalserveripaddress: 2603:10a6:150:351::5 x-ms-exchange-organization-originalclientipaddress: 45.156.32.33 acceptlanguage: et-EE, en-US msip_labels: MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Enabled=True;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SiteId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SetDate=2026-06-15T11:50:49.520Z;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Name=All Employees (unrestricted);MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_ContentBits=1;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Method=Standard; X-OlkEid: 00000000FBE30D4A7ED77B47974B2304BB4E84D8070034AD76187591974DBF6C4F76951C873A0100020000000000B3D5AF184A00AB4C8C167C2EB8411B9B00000000153F00004D803EF1B3E5124FAA1D20D0B483DD59 X-MS-Exchange-Organization-ModifySensitivityLabel: 00000000-0000-0000-0000-000000000000;defa4170-0d19-0005-0004-bc88714345d2 X-MS-Exchange-MessageSentRepresentingType: 1 This is a multipart message in MIME format. ------=_NextPart_000_00F3_01DD07B8.946CD440 Content-Type: text/plain; charset="iso-8859-1" Content-Transfer-Encoding: 8bit Selles e-kirjas sisalduv teave (kaasa arvatud manused) on mõeldud ametialaseks kasutamiseks ning seda võivad kasutada vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt väljendatud loata edasi saata ega mis tahes viisil kolmandatele isikutele avaldada. Juhul, kui Te olete saanud käesoleva e-kirja eksituse tõttu, teavitage sellest koheselt saatjat ning kustutage e-kiri. This e-mail and any attachments transmitted may contain confidential and privileged information. If you are not the intended recipient, please notify the sender immediately by returning the e-mail and permanently deleting what you have received. Any dissemination or use of this information by a third person without permission is prohibited and may be illegal. _____ Saatja: Hanneli Rudi > Saadetud: esmaspäev, 15. juuni 2026 11:03 Adressaat: Kommunikatsioon - RA > Teema: Palve EBUst Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Tere Pöördun teie poole taas oma EBU kolleegi palvel. Taani ametivõimude teatel on blokeeritud doonori NIMA spermat kasutatud Next Fertility Nordic kliinikus, mis tegutseb Tallinnas. Mu kolleeg soovib teada, kui RATC süsteemi kaudu edastatakse kiirhoiatus, mille tulemusena konkreetse doonori sperma kasutamine blokeeritakse, aga puudub vastav register ja ametivõimude järelevalve, siis kuidas tagatakse asjasse puutuvate perede teavitamine? Kas kliinik sai teada, aga ka kuidas kliinik peaks teada saama, et selle doonori spermat mitte kasutada? Loodan, et saan Teie vastuse lähipäevil. Hanneli Rudi AK toimetaja 55 35 816 ------=_NextPart_000_00F3_01DD07B8.946CD440 Content-Type: text/html; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable

 

Selles e-kirjas = sisalduv teave (kaasa arvatud manused) on m=F5eldud ametialaseks = kasutamiseks ning seda v=F5ivad kasutada vaid e-kirja adressaadid. = E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt v=E4ljendatud = loata edasi saata ega mis tahes viisil kolmandatele isikutele avaldada. = Juhul, kui Te olete saanud k=E4esoleva e-kirja eksituse t=F5ttu, = teavitage sellest koheselt saatjat ning kustutage e-kiri. 
This = e-mail and any attachments transmitted may contain confidential and = privileged information. If you are not the intended recipient, please = notify the sender immediately by returning the e-mail and = permanently deleting what you have received. Any dissemination or = use of this information by a third person without permission is = prohibited and may be illegal. 

Saatja: Hanneli Rudi <hanneli.rudi@err.ee>
Saa= detud: esmasp=E4ev, 15. juuni 2026 11:03
Adressaat: = Kommunikatsioon - RA <press@ravimiamet.ee>
Tee= ma: Palve EBUst

 

T=E4helepanu! Tegemist on v=E4lisv=F5rgust saabunud = kirjaga.
Tundmatu saatja korral palume linke ja faile mitte = avada.

Tere

 

P=F6=F6rdun teie poole taas oma EBU kolleegi = palvel. Taani ametiv=F5imude teatel on blokeeritud doonori NIMA spermat = kasutatud Next Fertility Nordic kliinikus, mis tegutseb = Tallinnas.

Mu kolleeg soovib teada, kui RATC s=FCsteemi = kaudu edastatakse kiirhoiatus, mille tulemusena konkreetse doonori = sperma kasutamine blokeeritakse, aga puudub vastav register ja = ametiv=F5imude j=E4relevalve, siis kuidas tagatakse asjasse puutuvate = perede teavitamine? Kas kliinik sai teada, aga ka kuidas kliinik peaks = teada saama, et selle doonori spermat mitte = kasutada?

 

Loodan, et saan Teie vastuse = l=E4hip=E4evil.

 

Hanneli Rudi

AK toimetaja

55 35 816

 

 

<= /body> ------=_NextPart_000_00F3_01DD07B8.946CD440--